# Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients.

> **NCT06663605** · PHASE1 · COMPLETED · sponsor: **Palisade Bio** · enrollment: 89 (actual)

## Conditions studied

- Ulcerative Colitis (UC)
- Healthy Volunteer

## Interventions

- **DRUG:** PALI-2108
- **DRUG:** PALI-2108 Placebo

## Key facts

- **NCT ID:** NCT06663605
- **Lead sponsor:** Palisade Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-05
- **Primary completion:** 2025-07-07
- **Final completion:** 2025-08-07
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2025-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06663605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06663605, "Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06663605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*